A new trial will study cancer ‘supersurvivors’, people who have survived after being diagnosed with advanced cancer to find out why they have lived longer than expected.
Cure51, a French techbio company launched the first global study of people still alive three to five years after being diagnosed with hard-to-treat forms of brain, lung or pancreatic cancer.
Researchers intend to gather tumour samples from over 1,000 exceptional responder patients in collaboration with eight NHS cancer centres.
Read more: https://news.sky.com/story/doctors-look-for-clues-on-why-super-survivors-overcome-cancer-in-first-global-study-13297748
#skynews #cancer #medicalstudy
SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews
Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
Follow us on TikTok: https://www.tiktok.com/@skynews
For more content go to http://news.sky.com and download our apps: Apple https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8 Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB
Sky News Daily podcast is available for free here: https://podfollow.com/skynewsdaily/
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí: https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog
To enquire about licensing Sky News content, you can find more information here: https://news.sky.com/info/library-sales
